WAT
stockOverall Healthy · 64%
- Fundamentals Strong
- Trajectory Steady
- Leadership Normal
A read across fundamentals, recent price & growth trajectory, and leadership stability. For fun and reading at a glance, not investment advice.
What the indicators say
Mixed 4 of 5 trend signals bullishRSI 68 — firm momentum, not yet overbought.
A mechanical reading of the chart’s indicators — not investment advice.
Key statsas of Jun 3
- Open
- $379.77
- +2.11%
- Close
- $379.77
- +2.11%
- Current
- $379.77
- Prev close
- $371.93
- Today
- 743.78K
- 3-mo avg
- 1.07M
Earningscalendar synced from Yahoo 57d ago
- Most recent
- May 577 days ago
- Next expected
- Jul 29in 8 days
Recent earnings dates
- May 5 77 days ago
- Feb 9 162 days ago
- Nov 4, 2025 259 days ago
- Aug 4, 2025 351 days ago
Past earnings dates come from WAT’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.
Fundamentalssynced from SEC 51d ago
Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Apr 2026 earnings, against the latest price), WAT’s fundamentals read as strong overall.
At 48.3x, the price is steep relative to profit; the stock leans heavily on growth that has yet to arrive.
Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.
This company pays no dividend, common for firms reinvesting their profits back into growth.
The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.
A 20.3% margin is strong; the company keeps a healthy slice of every revenue dollar.
The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.
A 25.1% return on equity is strong; the company compounds owners' capital well.
Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.
A 12.7% return on assets is strong; the company squeezes good profit from its assets.
Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.
At 0.98, the company carries less in liabilities than in equity, a conservative balance sheet.
Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.
At 1.73, short-term assets comfortably cover short-term bills.
Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.
Revenue grew 7.0% from the prior year: steady, modest expansion.
Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.
Net income grew 0.8% from the prior year: steady profit expansion.
Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.
Financialssynced from SEC 51d ago
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Revenue | $2.8B | $3.0B | $3.0B | $3.0B | $3.2B |
| Net income | $692.8M | $707.8M | $642.2M | $637.8M | $642.6M |
| Diluted EPS | $11.17 | $11.73 | $10.84 | $10.71 | $10.76 |
| Dividend / share | — | — | — | — | — |
| Total assets | $3.1B | $3.3B | $4.6B | $4.6B | $5.1B |
| Total liabilities | $2.7B | $2.8B | $3.5B | $2.7B | $2.5B |
| Shareholder equity | $367.6M | $504.5M | $1.2B | $1.8B | $2.6B |
| Q2-2024 | Q3-2024 | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $708.5M | $740.3M | $872.7M | $662.0M | $771.3M | $799.9M | $932.1M | $1.3B |
| Net income | $142.7M | $161.5M | $231.4M | $121.0M | $147.1M | $148.9M | $225.6M | -$72.0M |
| Diluted EPS | $2.40 | $2.71 | $3.88 | $2.03 | $2.47 | $2.50 | $3.76 | $-0.87 |
| Dividend / share | — | — | — | — | — | — | — | — |
Leadershipsynced from SEC 52d ago
- Batra Udit President and CEO · Director
- Chaubal Amol SVP & Chief Financial Officer
- Bennett Jianqing SVP Waters Adv. Diagnostics
- Carpio Robert L Iii SVP Waters Analytical Sciences
- Fearon Richard H Director
- Jiang Wei Director
- Knight Heather Director
Officers and board are drawn from WAT’s recent SEC ownership filings (Forms 3, 4 and 5).
Recent leadership changes
Notable recent eventspast year
- May 28 +7.2% one-day move
- May 5 +13.5% one-day move
- Apr 30 +5.9% one-day move
- Apr 23 −6.9% one-day move
- Mar 12 New 6-month low (-31% off peak)
- Feb 9 −13.9% one-day move
- Feb 9 Officer or director change reported in an 8-K
- Nov 4, 2025 +6.3% one-day move
- Oct 1, 2025 +6.7% one-day move
Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.
Recent SEC filingssynced from SEC 51d ago
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- DEF 14A Proxy statement
- 8-K Current report
- 8-K Current report
- 10-K Annual report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- 8-K Current report